Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study.
OBJECTIVE
Patients with cancer, particularly those undergoing chemotherapy or radiotherapy, may develop oral mucositis. This is the first study to investigate the absorption profile of fentanyl buccal tablet (FBT) - an effervescent formulation of fentanyl indicated for the management of breakthrough pain in opioid-tolerant cancer patients - in patients with or without oral mucositis.


METHODS
In this open-label study, patients with or without oral mucositis self-administered a single 200 microg dose of FBT by placing the tablet between the upper gum and cheek above a molar tooth. Venous blood samples for measurement of plasma fentanyl concentrations were collected at regular intervals up to 8 hours following FBT administration. Parameters of interest included maximum plasma concentration (C(max)), time to reach C(max) (t(max)), area under the plasma concentration-time curve from time zero to 8 hours (AUC(8)), and AUC from time zero to the median t(max) (AUC(tmax)(')). Adverse events were monitored throughout the study. Oral mucosal examinations and measurements of vital signs were performed at intervals up to 8 hours following FBT administration.


RESULTS
Sixteen patients, 8 with and 8 without oral mucositis, received FBT and completed the study. The severity of oral mucositis was mild in the patients exhibiting this condition. Median C(max) values were comparable: 1.14 ng/mL (range 0.26-2.69 ng/mL) in patients with mucositis, and 1.21 ng/mL (range 0.21-2.34 ng/mL) in patients without mucositis. The t(max) was not significantly different in the two groups: median t(max) was 25.0 min (range 15-45 min) in patients with mucositis and 22.5 min (range 10-121 min) in patients without mucositis. Median AUC(tmax') values were 0.17 ng . h/mL (range 0.04-0.52 ng . h/mL) in patients with mucositis, and 0.20 ng . h/mL (range 0.00-0.65 ng . h/mL) in patients without mucositis. The corresponding AUC(8) values were 2.05 ng . h/mL (range 1.16-3.83 ng . h/mL) and 1.55 ng . h/mL (range 0.74-3.07 ng . h/mL), respectively. FBT was generally well tolerated in this small group. No application site adverse events or changes in oral mucosal assessments were reported.


CONCLUSIONS
The absorption profile of a single dose of FBT 200 microg was similar in patients with or without mild oral mucositis. The compound was generally well tolerated.
Darwish
Mona
M
Clinical Pharmacology, Cephalon, Inc., Frazer, Pennsylvania 19355, USA. mdarwish@celphalon.com
Kirby
Mary
M
Robertson
Philmore
P
Tracewell
William
W
Jiang
John G
JG
D000042:Absorption; D000278:Administration, Buccal; D000328:Adult; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D000970:Antineoplastic Agents / Q000009:adverse effects; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D010146:Pain / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D010414:Pennsylvania; D010865:Pilot Projects; D011878:Radiotherapy / Q000009:adverse effects; D012720:Severity of Illness Index; D013280:Stomatitis / Q000150:complications / Q000209:etiology / Q000378:metabolism*; D013607:Tablets
D000701:Analgesics, Opioid; D000970:Antineoplastic Agents; D013607:Tablets; D005283:Fentanyl
Clin Pharmacokinet. 2005;44(12):1279-86
16372825
Cancer Nurs. 2004 May-Jun;27(3):183-205
15238805
Cancer Control. 1999 Mar;6(2):136-145
10758542
Support Care Cancer. 2001 Jun;9(4):247-57
11430420
Oral Oncol. 1998 Jan;34(1):39-43
9659518
Pain. 1999 May;81(1-2):129-34
10353500
Oncol Nurs Forum. 1998 Oct;25(9):1623-6
9802057
Br J Haematol. 2000 Aug;110(2):292-9
10971384
Clin Ther. 2006 May;28(5):707-14
16861092
J Pain Symptom Manage. 1995 Apr;10(3):243-8
7629418
Oncol Nurs Forum. 2002 Aug;29(7):1051-7
12183754
Clin J Pain. 2006 Nov-Dec;22(9):805-11
17057563